InvestorsHub Logo
Followers 38
Posts 5557
Boards Moderated 0
Alias Born 02/25/2011

Re: Whalatane post# 98283

Tuesday, 01/17/2017 3:42:07 PM

Tuesday, January 17, 2017 3:42:07 PM

Post# of 428955
kiwi, that's a situation that has occurred but should begin to turn with increasing T2 coverage of Vascepa. In fact the biggest challenge now is educating Docs and pharmacists that GL is T4 and Branded V is is T2 - their 1st impulse to is to expect the Generic Lovaza is preferred when now, for many plans it is not

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News